tiprankstipranks
Trending News
More News >
Biolife Sciences (BLFE)
OTHER OTC:BLFE
US Market

Biolife Sciences (BLFE) Ratios

Compare
57 Followers

Biolife Sciences Ratios

BLFE's free cash flow for Q1 2022 was $0.00. For the 2022 fiscal year, BLFE's free cash flow was decreased by $ and operating cash flow was $0.00. See a summary of the company’s cash flow.
Ratios
TTM
Nov 20Nov 19Nov 18Nov 17
Liquidity Ratios
Current Ratio
0.09 0.09 0.01 <0.01
Quick Ratio
0.09 0.09 0.01 <0.01
Cash Ratio
0.05 0.05 0.01 <0.01
Solvency Ratio
-1.39 -1.39 145.80 -0.24
Operating Cash Flow Ratio
-1.16 -1.16 0.01 -0.08
Short-Term Operating Cash Flow Coverage
-4.66 -4.66 0.00 -0.17
Net Current Asset Value
$ -690.57K$ -690.57K$ -1.15K$ -220.87K
Leverage Ratios
Debt-to-Assets Ratio
2.61 2.61 0.00 107.72
Debt-to-Equity Ratio
-0.27 -0.27 0.00 -0.64
Debt-to-Capital Ratio
-0.38 -0.38 0.00 -1.81
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 -0.43
Financial Leverage Ratio
-0.11 -0.11 -0.01 >-0.01
Debt Service Coverage Ratio
-5.10 -5.10 0.00 -0.49
Interest Coverage Ratio
-25.22 -25.22 0.00 -4.05
Debt to Market Cap
1.21 <0.01 0.00 <0.01
Interest Debt Per Share
<0.01 <0.01 0.00 <0.01
Net Debt to EBITDA
-0.13 -0.13 >-0.01 -3.33
Profitability Margins
Gross Profit Margin
-239.25%-239.25%0.00%0.00%
EBIT Margin
-295.85%-295.85%0.00%0.00%
EBITDA Margin
-295.95%-295.95%0.00%0.00%
Operating Profit Margin
-302.17%-302.17%0.00%0.00%
Pretax Profit Margin
-307.99%-307.99%0.00%0.00%
Net Profit Margin
-307.99%-307.99%0.00%0.00%
Continuous Operations Profit Margin
-307.99%-307.99%0.00%0.00%
Net Income Per EBT
100.00%100.00%100.00%100.00%
EBT Per EBIT
101.93%101.93%0.00%124.68%
Return on Assets (ROA)
-1743.72%-1743.72%-6670.59%-3993.56%
Return on Equity (ROE)
367.14%183.88%98.27%23.87%
Return on Capital Employed (ROCE)
180.40%180.40%0.00%27.42%
Return on Invested Capital (ROIC)
248.80%248.80%0.00%53.74%
Return on Tangible Assets
-1743.72%-1743.72%-6670.59%-3993.56%
Earnings Yield
-24489.17%-2.17%>-0.01%-0.12%
Efficiency Ratios
Receivables Turnover
0.00 0.00 0.00 0.00
Payables Turnover
2.83 2.83 0.00 0.00
Inventory Turnover
0.00 0.00 0.00 0.00
Fixed Asset Turnover
415.43 415.43 0.00 0.00
Asset Turnover
5.66 5.66 0.00 0.00
Working Capital Turnover Ratio
-1.19 -1.19 0.00 0.00
Cash Conversion Cycle
-128.82 -128.82 0.00 0.00
Days of Sales Outstanding
0.00 0.00 0.00 0.00
Days of Inventory Outstanding
0.00 0.00 0.00 0.00
Days of Payables Outstanding
128.82 128.82 0.00 0.00
Operating Cycle
0.00 0.00 0.00 0.00
Cash Flow Ratios
Operating Cash Flow Per Share
-0.02 -0.02 <0.01 >-0.01
Free Cash Flow Per Share
-0.02 -0.02 <0.01 >-0.01
CapEx Per Share
<0.01 <0.01 0.00 0.00
Free Cash Flow to Operating Cash Flow
1.00 1.00 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
-920.20 -920.20 0.00 0.00
Capital Expenditure Coverage Ratio
-920.20 -920.20 0.00 0.00
Operating Cash Flow Coverage Ratio
-4.66 -4.66 0.00 -0.09
Operating Cash Flow to Sales Ratio
-2.15 -2.15 0.00 0.00
Free Cash Flow Yield
-565.01%-1.51%<0.01%-0.03%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
>-0.01 -46.14 -40.31K -867.07
Price-to-Sales (P/S) Ratio
0.38 142.12 0.00 0.00
Price-to-Book (P/B) Ratio
>-0.01 -84.85 -39.61K -206.95
Price-to-Free Cash Flow (P/FCF) Ratio
-0.18 -66.09 2.69M -3.65K
Price-to-Operating Cash Flow Ratio
>-0.01 -66.16 2.69M -3.65K
Price-to-Earnings Growth (PEG) Ratio
>-0.01 >-0.01 418.57 8.99
Price-to-Fair Value
>-0.01 -84.85 -39.61K -206.95
Enterprise Value Multiple
-0.26 -48.15 265.96 -1.08K
Enterprise Value
311.53K 58.66M 45.71M 45.85M
EV to EBITDA
-0.26 -48.15 265.96 -1.08K
EV to Sales
0.76 142.49 0.00 0.00
EV to Free Cash Flow
-0.35 -66.27 2.69M -3.66K
EV to Operating Cash Flow
-0.35 -66.34 2.69M -3.66K
Tangible Book Value Per Share
-0.01 -0.01 >-0.01 -0.01
Shareholders’ Equity Per Share
-0.01 -0.01 >-0.01 -0.01
Tax and Other Ratios
Effective Tax Rate
0.00 0.00 0.00 0.00
Revenue Per Share
<0.01 <0.01 0.00 0.00
Net Income Per Share
-0.02 -0.02 >-0.01 >-0.01
Tax Burden
1.00 1.00 1.00 1.00
Interest Burden
1.04 1.04 0.00 1.25
Research & Development to Revenue
0.00 0.00 0.00 0.00
SG&A to Revenue
0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00
Income Quality
0.70 0.70 -0.01 0.24
Currency in USD